Pharmacy benefit manager Catamaran (NASDAQ:CTRX) was the big loser in health care today, with shares falling more than 10% after an earnings report that contained some disappointment. While the company beat on earnings by $0.02 per share and came out handily ahead on the top line, 2014 guidance was the real issue. The company guided for an EPS of $2.04-$2.19 for the year, a big difference from the $2.41 the market was expecting.

However, Motley Fool health-care analyst David Williamson still really likes the company and its use of analytics. In the following video, David gives investors some of the key strengths he sees in the company, and discusses why Obamacare will give this company a strong competitive advantage down the road.

Do you know how the changing face of American health care will affect your portfolio?
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." This free guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

David Williamson has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Catamaran. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Compare Brokers